Inhaled Nitric Oxide in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy

计划入组 36 人 · 首次发布于 2023 年 5 月 23 日

Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers

计划入组 240 人 · 首次发布于 2015 年 6 月 8 日

INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma

计划入组 35 人 · 首次发布于 2018 年 4 月 19 日

INO-5151

INO-4212

INO-3107

INO THERAPEUTICS LLC

United States

Inovio Pharmaceuticals

United States

Ico Therapeutics Inc.

Canada

INOVIO and Akeso Partner to Test Novel DNA-Bispecific Antibody Combination for Glioblastoma Treatment

INOVIO's INO-3107 Demonstrates T Cell Expansion and Reduced Surgeries in RRP Trial

INOVIO's INO-3107 Shows Promise in Recurrent Respiratory Papillomatosis Treatment